Becker's Healthcare December 11, 2023
Rylee Wilson

The federal government will cap drug copays and premiums for Medicare beneficiaries and expand eligibility for financial assistance for medications in 2024.

The new policies are part of the Inflation Reduction Act, passed in 2022, and being rolled out over several years. In 2023, the legislation led to caps on insulin prices for Medicare beneficiaries and financial penalties for drugmakers raising the cost of their medications higher than the rate of inflation.

AARP laid out when the act’s provisions take effect, year-by-year. Here are three big changes coming to Medicare in 2024:

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article